These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15809548)

  • 1. Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD.
    Mahler DA; Fierro-Carrion G; Mejia-Alfaro R; Ward J; Baird JC
    Med Sci Sports Exerc; 2005 Apr; 37(4):529-35. PubMed ID: 15809548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
    Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD.
    Elbehairy AF; Webb KA; Laveneziana P; Domnik NJ; Neder JA; O'Donnell DE;
    Respir Physiol Neurobiol; 2018 Jun; 252-253():64-71. PubMed ID: 29578103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.
    Guenette JA; Webb KA; O'Donnell DE
    Respir Med; 2013 May; 107(5):708-16. PubMed ID: 23421968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
    Diba C; King GG; Berend N; Salome CM
    Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exercise.
    Calligaro GL; Raine RI; Bateman ME; Bateman ED; Cooper CB
    COPD; 2014 Feb; 11(1):105-12. PubMed ID: 24152211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocol.
    Sava F; Perrault H; Brouillard C; Darauay C; Hamilton A; Bourbeau J; Maltais F
    COPD; 2012 Aug; 9(4):395-400. PubMed ID: 22509905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM.
    Baldi BG; de Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
    Respir Med; 2013 Nov; 107(11):1773-80. PubMed ID: 24064347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Respir Physiol Neurobiol; 2010 Aug; 173(1):58-63. PubMed ID: 20601207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of endurance treadmill walking compared with cycling to assess bronchodilator therapy.
    Zhang X; Waterman LA; Ward J; Baird JC; Mahler DA
    Chest; 2010 Jun; 137(6):1354-61. PubMed ID: 20040610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
    O'Donnell DE; Hamilton AL; Webb KA
    J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD.
    Berton DC; Barbosa PB; Takara LS; Chiappa GR; Siqueira AC; Bravo DM; Ferreira LF; Neder JA
    Thorax; 2010 Jul; 65(7):588-93. PubMed ID: 20627914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.
    Abdallah SJ; Smith BM; Ware MA; Moore M; Li PZ; Bourbeau J; Jensen D
    Ann Am Thorac Soc; 2018 Oct; 15(10):1146-1158. PubMed ID: 30049223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung function and exercise tolerance after treatment with salmeterol or ipratropium bromide in chronic obstructive pulmonary disease].
    Grzanka A; Pitsch T; Krzywiecki A; Rogala B
    Pol Merkur Lekarski; 2004 Sep; 17(99):208-11. PubMed ID: 15628041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.
    Oga T; Nishimura K; Tsukino M; Sato S; Hajiro T; Mishima M
    Chest; 2003 Jun; 123(6):1810-6. PubMed ID: 12796154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
    Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
    Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
    Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyspnea ratings for prescription of cross-modal exercise in patients with COPD.
    Horowitz MB; Mahler DA
    Chest; 1998 Jan; 113(1):60-4. PubMed ID: 9440569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.